What should I pay attention to before using Sparsentine?

Sparsentan, this innovative drug, is mainly used to treat primary immunoglobulin A nephropathy (IgAN), which is a disease caused by the deposition of immunoglobulin A in the kidneys, which can seriously damage kidney function.

Spaxentan has the potential to cause liver damage. If you have a history of liver disease, cirrhosis or liver disease after taking medication, or if you have recurrent gallstones, be sure to tell your doctor. Depending on your individual situation, your doctor may recommend that you avoid spaxentan. At the same time, if you have a drinking habit or have consumed large amounts of alcohol, please inform your doctor, as alcohol may increase the risk of liver damage. Excessive alcohol consumption should be avoided during sparsentan treatment. If you experience symptoms such as extreme fatigue, upper right abdominal pain, nausea, vomiting, yellowing of the skin or eyes, or dark yellow urine, please contact your physician immediately.

Sparsentane is strictly contraindicated in patients who are or may become pregnant as it may cause birth defects in the newborn. Patients should take a pregnancy test before starting sparsentane, during treatment, and for one month after stopping treatment. To avoid pregnancy, potentially pregnant patients must use effective contraception during the above time periods.

At this stage, although Sparsentin is not officially sold in the country, it has entered the market through overseas channels. The prices vary according to specifications, manufacturers and regions. For example, the original research version of Sparsentan is sold overseas in a package of 30 tablets of 200mg, priced at about 10,000 yuan, and the price may fluctuate due to exchange rate changes. At the same time, the market price of 400 mg 30 tablets of sparsentan produced by Lucius Pharmaceuticals in Laos is about 7,800 yuan. When patients purchase sparsentane, they should do so through formal channels and use it strictly in accordance with medical instructions. If you have any uncertainties or need more consultation, it is recommended to contact a professional overseas medical consultant to ensure the reliability of the information and the smooth progress of treatment.

To sum up, before using sparsentan, patients need to fully understand the drug information and work closely with their doctors to ensure the personalized and safe treatment plan. By following medical advice and regular monitoring, patients can better take advantage of sparsentan, an innovative drug, to effectively manage IgAN disease.

xa0

Reference link: https://medlineplus.gov/druginfo/meds/a623018.html